DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.55
+0.40 (6.50%)
At close: Jun 26, 2026, 4:00 PM EDT
6.55
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
DiaMedica Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for DiaMedica Therapeutics stock have an average target of 17, with a low estimate of 12 and a high estimate of 25. The average target predicts an increase of 159.54% from the current stock price of 6.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2026.
Analyst Ratings
The average analyst rating for DiaMedica Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 18, 2026 |
| Lake Street | Lake Street | Buy Maintains $14 | Buy | Maintains | $14 | +113.74% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +83.21% | May 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $25 | Buy | Maintains | $25 | +281.68% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.58
from -0.49
EPS Next Year
-0.62
from -0.58
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.58 | -0.62 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.